AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 28th, 2022 • Acumen Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Virginia
Contract Type FiledMarch 28th, 2022 Company Industry JurisdictionThis AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective January 1, 2022 (the “Effective Date”), by and between Daniel J. O’Connell (the “Executive”) and Acumen Pharmaceuticals, Inc. (the “Company”) and supersedes and replaces any prior consulting agreement or employment letter between the Parties and any of their affiliates.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 28th, 2022 • Acumen Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Indiana
Contract Type FiledMarch 28th, 2022 Company Industry JurisdictionThis AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective January 1, 2022 (the “Effective Date”), by and between Russell Barton (the “Executive”) and Acumen Pharmaceuticals, Inc. (the “Company”) and supersedes and replaces any prior consulting agreement or employment letter between the Parties and any of their affiliates.